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Validity of Instrumented Medicine Ball Measurements
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Introduction.
Medicine balls are a popular training tool for athletes. While previous research has
demonstrated the importance of medicine ball throwing for sports performance
and rehabilitation [1-6], its simplicity and training environment make it challenging
to quantify metrics for these applications. Therefore, the ability to measure
movement-specific outcomes using a medicine ball (e.g. power, velocity) would
provide coaches and clinicians a better understanding of the physical capabilities
of an athlete/patient and allow them to quantitatively track performance
throughout a training or rehabilitation program. The Ballistic Ball, a proprietary
instrumented medicine ball (FIT7502 LLC, Colorado, USA), contains an inertial
measurement unit (IMU) in the center of the ball. The ball works by transmitting
data from the IMU to a software application, where the data is used to quantify
various metrics from each throw, such as power, speed, force, launch angle, and
distance thrown. The purpose of this study was to assess the validity of different
Ballistic Ball throw metrics performed across a range of exercises and conditions.
Methods.
This study was determined to be non-human subjects research by the Sanford IRB.
Data was collected from a single individual (M|26yrs|79.4kg|1.77m). Three throw
types (vertical, rotational, and chest pass) with two balls (4.54 kg (10lbs), 100.33cm
circumference and 3 kg, 72.39cm circumference) were collected. Concentric-only
(static) and eccentric-concentric (dynamic) conditions were recorded for each
throw type. The subject performed two sets of six repetitions for each throw type
and condition at maximal and submaximal intensities. A total of 156 throws were
conducted. Optical motion capture was used to collect 3D positional data of the
medicine ball with eight motion capture cameras (Oqus 7+, Qualisys AB, Sweden)
operating at 300 Hz. A set of 13 retroreflective markers were placed on each
medicine ball, including a cluster of four tracking markers, two clusters of three
tracking markers, and three markers along the radius of the ball to define the
spherical shape. Peak speed, POP-100TM (a proprietary variable of FIT7502), and
launch angle were calculated and compared with the variables reported in the
software application. Analysis of variance (ANOVA) tests were used to determine
differences between devices and the effect of the device, exercise performed,
condition of the exercise (static or dynamic), intensity, ball size, and potential
interaction effects. A combination of Pearson’s correlation, linear regression, and
Bland-Altman analyses were used to assess the between device agreement.
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Results.
Across all trials, a near-perfect agreement between the IMU and gold-standard
motion capture system was observed for peak speed and launch angle, with a
significant but relatively small bias. ANOVA tests revealed no significant differences
between motion capture and the Ballistic Ball for peak speed with no significant
interaction of devices for exercises, conditions, intensities, and ball sizes. Launch
angle was significantly affected by the interaction of the device, movement, and
condition (F=8.61, p<0.01); Bonferroni post hoc analysis revealed significant
differences between motion capture and the Ballistic Ball (p=0.049). Simple main
effects revealed a significant difference for launch angle between motion capture
and the Ballistic Ball for the chest pass exercise in the dynamic condition at
submaximal effort with the larger ball size (p<0.05). POP-100TM was significantly
affected by the interaction of the device (F=47.57, p<0.01), condition, and ball size,
as well as by the interaction of the device, movement, and ball size (F=10.81,
p<0.01); post hoc analysis revealed significant differences between motion capture
and the Ballistic Ball (p<0.01). Simple main effects showed a significant difference
for POP-100TM between motion capture and the Ballistic Ball for the chest pass
exercise in the static condition at maximal intensity with the smaller ball (p<0.05).
Discussion.
The purpose of this study was to assess the validity of the metrics output by the
Ballistic Ball. While no agreement was observed between motion capture and the
Ballistic Ball for POP-100TM for static throws, POP-100TM was found to be a valid
measurement for throws containing a countermovement as part of the throw
condition. Additionally, the Ballistic Ball provides valid measurements of launch
angle for vertical throw exercises at various conditions and effort levels. Peak
speed was shown to be valid across a range of exercises, conditions, and effort
levels with negligible bias. The overall validity of the Ballistic Ball offers clinicians
and coaches a tool that they can confidently use to quantify medicine ball
performance metrics for athletic development and rehabilitation.
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